Transform Wealth, LLC Biogen Inc. Transaction History

Transform Wealth, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Jul 30, 2019	SELL	$219.29 - $241.72 $2.95 Million - $3.25 Million	-13,431 Closed	0 $0
Q1 2019 Apr 12, 2019	BUY	$216.71 - $338.96 $1.19 Million - $1.86 Million	5,496 Added 69.26%	13,431 $3.18 Million
Q4 2018 Jan 30, 2019	BUY	$278.5 - $352.75 $2.03 Million - $2.58 Million	7,305 Added 1159.52%	7,935 $2.39 Million
Q3 2018 Oct 25, 2018	SELL	$293.51 - $383.83 $187,552 - $245,267	-639 Reduced 50.35%	630 $223,000
Q2 2018 Aug 03, 2018	BUY	$257.52 - $306.91 $94,509 - $112,635	367 Added 40.69%	1,269 $368,000
Q1 2018 May 03, 2018	SELL	$260.13 - $367.91 $1.24 Million - $1.75 Million	-4,761 Reduced 84.07%	902 $247,000
Q4 2017 Feb 08, 2018	BUY	$307.64 - $344.58 $119,364 - $133,697	388 Added 7.36%	5,663 $1.8 Million
Q3 2017 Oct 19, 2017	BUY	$281.15 - $329.69 $1.48 Million - $1.74 Million	5,275	5,275 $1.65 Million

1,023

128M

1.22M

1.4M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $26.1B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Transform Wealth, LLC, based on Form 13F filings with the SEC.

Stay updated on Transform Wealth, LLC with notifications on news.